相关实验视频
Updated: Jul 26, 2025
07:08
Burn Injury-Induced Pain and Depression-Like Behavior in Mice
Published on: September 29, 2021
3.2K
在疼痛和抑郁症的并发症中GABAergic系统的作用
Siqi Yang1, Bingyuan Zhang2, Di Wang1
1Department of Anesthesiology and Perioperative Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029. China.
Brain research bulletin
|June 18, 2023
概括
慢性疼痛和抑郁症经常同时发生,相互恶化. 这篇评论探讨了GABAergic系统.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 疼痛研究 疼痛研究
背景情况:
- 慢性疼痛和抑郁症经常同时存在,严重影响患者的生活质量.
- 疼痛和抑郁之间的双向关系带来了诊断和治疗方面的挑战.
- 了解这种并发症的分子基础对于开发有效的治疗方法至关重要.
研究的目的:
- 审查GABAergic系统在慢性疼痛和抑郁症并发症中的作用.
- 为了检查GABAergic系统与其他相关系统之间的相互作用,在这种共同疾病中.
- 提供对这些条件之间的复杂相互作用的全面了解.
主要方法:
- 关于GABAergic系统,慢性疼痛和抑郁症现有研究的文献综述.
- 对探索GABAergic系统与其他神经生物学系统之间的相互作用的研究进行分析.
- 综合证据以阐明疼痛抑郁症并发症背后的分子机制.
主要成果:
- GABAergic系统在慢性疼痛和抑郁症中起着重要作用.
- GABAergic系统与其他系统 (例如,血清激素,多巴胺激素) 之间的相互作用在并发症中至关重要.
- 有证据表明,GABAergic信号的失调有助于两种情况的恶化.
结论:
- 该GABAergic系统是慢性疼痛和抑郁症共患病的关键参与者.
- 针对GABAergic系统及其与其他系统的相互作用可能提供新的治疗策略.
- 需要采用综合性方法,才能充分理解和治疗这种复杂的并发症.
相关概念视频
01:21G-protein Coupled Receptors
120.4K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
120.4K
01:28Depressants
145
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
145
01:25Analgesia and Pain Management
668
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
668
01:18Depression: Overview
288
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
288
01:27Depressive Disorders: Etiology
144
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
144
01:14CNS Depressants: Barbiturates and Benzodiazepines
350
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
350